StockData
Immunic, Inc. logo

Immunic, Inc. (IMUX) stock

IMUXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$7.33+0.10 (+1.38%)

Close on Nov 17, 2026Market cap $100.01MP/E –Yield 0.00%

Immunic price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

No price to sales ratio figures for Immunic

Immunic has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Immunic figures

See a number that looks wrong?